Tip: Index histories & All-time highs

Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Thu, 19.09.2024       Baader Bank AG
DE0005088108

Baader Bank increases forecast for financial year 2024 All data is based on provisional and unaudited consolidated figures.   Baader Bank Aktiengesellschaft is revising its previous forecast for the 2024 financial year upwards. Following a significant increase in the Group's pre-tax profit of EUR 20.3 million in the first half of 2024, the season [ … ]
Technical analysis
To the publication
Thu, 19.09.2024       Baader Bank AG
DE0005088108

Baader Bank increases forecast for financial year 2024 All data is based on provisional and unaudited consolidated figures.   Baader Bank Aktiengesellschaft is revising its previous forecast for the 2024 financial year upwards. Following a significant increase in the Group's pre-tax profit of EUR 20.3 million in the first half of 2024, the season [ … ]
Technical analysis
To the publication
Thu, 19.09.2024       Kontron AG
AT0000A0E9W5

  Unique in-house production strengthens technological independence   Linz, Austria, 19. September 2024 – Kontron AG, a leading global provider of IoT technology, will henceforth fully manufacture its innovative 5G modules in Europe following a successful production ramp-up. By producing in its own European facilities, the company is underlining [ … ]
Technical analysis
To the publication
Thu, 19.09.2024       Kontron AG
AT0000A0E9W5

  Unique in-house production strengthens technological independence   Linz, Austria, 19. September 2024 – Kontron AG, a leading global provider of IoT technology, will henceforth fully manufacture its innovative 5G modules in Europe following a successful production ramp-up. By producing in its own European facilities, the company is underlining [ … ]
Technical analysis
To the publication
Thu, 19.09.2024       Xlife Sciences AG
CH0461929603

Zurich, 19th of September 2024: Xlife Sciences AG (SIX: XLS) today published its 2024 Half-Year Report and announced significant progress in its business development. Despite a challenging market environment, the company was able to further expand its innovative strength and advance new partnerships and developments within its diversified portfolio [ … ]
Technical analysis
To the publication
Thu, 19.09.2024       Xlife Sciences AG
CH0461929603

Zurich, 19th of September 2024: Xlife Sciences AG (SIX: XLS) today published its 2024 Half-Year Report and announced significant progress in its business development. Despite a challenging market environment, the company was able to further expand its innovative strength and advance new partnerships and developments within its diversified portfolio [ … ]
Technical analysis
To the publication
Thu, 19.09.2024       AEVIS VICTORIA SA
CH0478634105

Ad hoc announcement pursuant to Art. 53 LR Fribourg, 19 September 2024 AEVIS VICTORIA SA (AEVS.SW) – Publication of Half-Year Report 2024 – Revenue up 8.0% to CHF 527.6 million – Operating profit at EBITDAR level up 21.3% to CHF 87.7 million AEVIS VICTORIA SA (AEVIS), a key player in the healthcare, hospitality, and real estate sectors, today  [ … ]
Technical analysis
To the publication
Thu, 19.09.2024       AEVIS VICTORIA SA
CH0478634105

Ad hoc announcement pursuant to Art. 53 LR Fribourg, 19 September 2024 AEVIS VICTORIA SA (AEVS.SW) – Publication of Half-Year Report 2024 – Revenue up 8.0% to CHF 527.6 million – Operating profit at EBITDAR level up 21.3% to CHF 87.7 million AEVIS VICTORIA SA (AEVIS), a key player in the healthcare, hospitality, and real estate sectors, today  [ … ]
Technical analysis
To the publication
Thu, 19.09.2024       Newron Pharmaceuticals S.p.A.
IT0004147952

Newron presents H1 2024 results and provides business update  Milan, Italy, September 19, 2024, 7 am CET – Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system, today announced its financial [ … ]
Technical analysis
To the publication
Thu, 19.09.2024       Newron Pharmaceuticals S.p.A.
IT0004147952

Newron presents H1 2024 results and provides business update  Milan, Italy, September 19, 2024, 7 am CET – Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system, today announced its financial [ … ]
Technical analysis
To the publication

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
About the newsfeed
#1
Where does the information come from?

The information is provided as part of a content partnership by one of Europe's leading news data providers, the Munich-based EQS Group.

#2
Will editorial changes be made?
The portal site is part of the EQS-Newswire distribution network. The information is provided 'as is'. No editorial adjustments are made. The detailed views are enriched with additional information in order to offer interested investors further research options.
#3
From which news source does the information originate?
As a rule, it is the companies themselves that provide information, either through their own public relations work or via partner agencies. Due to the wide reach of the EQS distribution network and the associated multiplier effects, this service is often used to reach interested parties quickly and in a targeted manner. The EQS Group counts almost all listed companies among its customers.
#4
Are the messages provided in real time?

The data feeds are updated at regular intervals. You can obtain the latest information directly from EQS if required. Simply follow the link below.

#5
Are there plans to expand the scope of the news?

If investor-relevant topics are involved, it is possible to connect additional data providers. In Q1/2024, mwb Research was added to the information offering in the rating area.

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Thursday, 28.11.2024, Calendar Week 48, 333rd day of the year, 33 days remaining until EoY.